The 10nm diameter microfibrils are extracellular matrix components that provide crucial physiomechanic properties to a wide variety of elastic and non-elastic tissues. Very little is known about the composition of the microfibrils, the way they are assembled, and the factors that regulate this process. The major and best characterized component of the microfibrils is fibrillin-1, a 350-kDa glycoprotein made of repeated EGF-like motifs interspersed among other cysteine-rich sequences. Mutations in fibrillin-1 are the cause of the clinical manifestations in individuals with Marfan syndrome. Work sponsored by this grant has led to the identification of another microfibrillar component structurally related to fibrillin-1, and thus termed fibrillin-2. It has also documented the diversified pattern of gene expression of the fibrillins during embryogenesis and within individual organ systems. Others have very recently corroborated the previous linkage data by identifying fibrillin-2 mutations in patients affected by Congenital Contractural Arachnodactyly, a condition that shares some of the skeletal manifestations of Marfan syndrome. Altogether, these observations support our original hypothesis or related but distinct roles for the fibrillins in the assembly and function of tissue-specific matrices. In this competing continuation, we expand further the formulation of this early hypothesis. Accordingly, we propose that transcriptional programs which modulate the developmental production of fibrillin proteins are ultimately responsible for the tissue-specific function of microfibrillar aggregates and elastic networks. Experiments described in this proposal are aimed at elucidating the function of fibrillin-2 in matrix assembly and maintenance, and at characterizing the spatio-temporal regulation of the fibrillin genes. Like int he past, they will closely interact with colleagues working on the ultrastructural aspects of microfibril assembly and elastogenesis, and the molecular genetics of human connective tissue disorders. Collectively, results of these studies will enhance our understanding of microfibril biology; shed new light on macromolecular assemblies in normal and diseased states; and clarify the range of contributions of the extracellular matrix to animal morphogenesis and development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR042044-06
Application #
2683306
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1993-04-01
Project End
2000-03-31
Budget Start
1998-04-01
Budget End
1999-03-31
Support Year
6
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Biochemistry
Type
Schools of Medicine
DUNS #
114400633
City
New York
State
NY
Country
United States
Zip Code
10029
Cook, J R; Carta, L; Galatioto, J et al. (2015) Cardiovascular manifestations in Marfan syndrome and related diseases; multiple genes causing similar phenotypes. Clin Genet 87:11-20
Cook, Jason R; Ramirez, Francesco (2014) Clinical, diagnostic, and therapeutic aspects of the Marfan syndrome. Adv Exp Med Biol 802:77-94
Cook, Jason R; Smaldone, Silvia; Cozzolino, Carmine et al. (2012) Generation of Fbn1 conditional null mice implicates the extracellular microfibrils in osteoprogenitor recruitment. Genesis 50:635-41
Smaldone, Silvia; Carta, Luca; Ramirez, Francesco (2011) Establishment of fibrillin-deficient osteoprogenitor cell lines identifies molecular abnormalities associated with extracellular matrix perturbation of osteogenic differentiation. Cell Tissue Res 344:511-7
Arteaga-Solis, Emilio; Sui-Arteaga, Lee; Kim, Minwook et al. (2011) Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. Matrix Biol 30:188-94
Nistala, Harikiran; Lee-Arteaga, Sui; Smaldone, Silvia et al. (2010) Fibrillin-1 and -2 differentially modulate endogenous TGF-? and BMP bioavailability during bone formation. J Cell Biol 190:1107-21
Chernousov, Michael A; Baylor, Kelly; Stahl, Richard C et al. (2010) Fibrillin-2 is dispensable for peripheral nerve development, myelination and regeneration. Matrix Biol 29:357-68
Charbonneau, Noe L; Carlson, Eric J; Tufa, Sara et al. (2010) In vivo studies of mutant fibrillin-1 microfibrils. J Biol Chem 285:24943-55
Charbonneau, Noe L; Jordan, C Diana; Keene, Douglas R et al. (2010) Microfibril structure masks fibrillin-2 in postnatal tissues. J Biol Chem 285:20242-51
Nistala, Harikiran; Lee-Arteaga, Sui; Carta, Luca et al. (2010) Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome. Hum Mol Genet 19:4790-8

Showing the most recent 10 out of 33 publications